We provide you with 20 years of free, institutional-grade data for VKTX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of VKTX. Explore the full financial landscape of VKTX stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Aubuchon Neil William | Open Market Purchase | 4,475 | $33.5 | 2026-03-10 | |
| Mancini Marianna | Sale | -57,661 | $32.29 | $1,862,035 | 2026-01-05 |
| Mancini Marianna | Grant, award...etc | 73,049 | 2026-01-05 | ||
| Lian Brian | Sale | -233,409 | $32.29 | $7,536,940 | 2026-01-05 |
| Lian Brian | Grant, award...etc | 302,480 | 2026-01-05 | ||
| SINGLETON J MATTHEW | Grant, award...etc | 3,150 | 2026-01-05 | ||
| MACARTNEY LAWSON | Grant, award...etc | 3,150 | 2026-01-05 | ||
| Rowland Charles A Jr | Grant, award...etc | 3,150 | 2026-01-05 | ||
| FOEHR MATTHEW W | Grant, award...etc | 3,150 | 2026-01-05 | ||
| FOEHR MATTHEW W | Sale | -16,000 | $35.11 | $561,694 | 2026-01-05 |
| FOEHR MATTHEW W | Derivatives Exercise | 16,000 | 2026-01-05 | ||
| Rouan Sarah Kathryn | Grant, award...etc | 3,150 | 2026-01-05 | ||
| ZANTE GREG | Sale | -57,661 | $32.3 | $1,862,162 | 2026-01-05 |
| ZANTE GREG | Grant, award...etc | 73,049 | 2026-01-05 | ||
| Rowland Charles A Jr | Sale | -60,000 | $35.57 | $2,134,278 | 2025-10-28 |
| Rowland Charles A Jr | Grant, award...etc | 60,000 | $4.48 | 2025-10-28 | |
| Lian Brian | Sale | -38,989 | $35.01 | $1,364,923 | 2025-10-28 |
| Lian Brian | Grant, award...etc | 70,084 | 2025-10-28 | ||
| ZANTE GREG | Sale | -6,185 | $35 | $216,481 | 2025-10-28 |
| ZANTE GREG | Grant, award...etc | 11,117 | 2025-10-28 | ||
| Mancini Marianna | Sale | -6,185 | $35 | $216,492 | 2025-10-28 |
| Mancini Marianna | Grant, award...etc | 11,117 | 2025-10-28 | ||
| ZANTE GREG | Sale | -4,266 | $27.76 | $118,428 | 2025-07-03 |
| ZANTE GREG | Grant, award...etc | 7,667 | 2025-07-03 | ||
| Mancini Marianna | Sale | -4,266 | $27.77 | $118,473 | 2025-07-03 |
| Mancini Marianna | Grant, award...etc | 7,667 | 2025-07-03 | ||
| Lian Brian | Sale | -26,889 | $27.8 | $747,633 | 2025-07-03 |
| Lian Brian | Grant, award...etc | 48,333 | 2025-07-03 | ||
| FOEHR MATTHEW W | Derivatives Exercise | 20,786 | 2025-04-14 | ||
| Rouan Sarah Kathryn | Open Market Purchase | 1,240 | $24.15 | 2025-04-08 | |
| Rouan Sarah Kathryn | Open Market Purchase | 1,240 | $24.15 | 2025-04-02 | |
| ZANTE GREG | Sale | -50,309 | $42.69 | $2,147,631 | 2025-01-06 |
| ZANTE GREG | Grant, award...etc | 66,200 | 2025-01-06 | ||
| Mancini Marianna | Sale | -54,215 | $42.69 | $2,314,400 | 2025-01-06 |
| Mancini Marianna | Grant, award...etc | 66,200 | 2025-01-06 | ||
| Lian Brian | Sale | -194,490 | $42.68 | $8,301,572 | 2025-01-06 |
| Lian Brian | Grant, award...etc | 256,133 | 2025-01-06 | ||
| MACARTNEY LAWSON | Sale | -2,000 | $68.67 | $137,333 | 2024-11-08 |
| MACARTNEY LAWSON | Derivatives Exercise | 2,000 | 2024-11-08 | ||
| ZANTE GREG | Sale | -131,687 | $74.56 | $9,818,451 | 2024-10-28 |
| ZANTE GREG | Derivatives Exercise | 94,001 | 2024-10-28 | ||
| SINGLETON J MATTHEW | Sale | -16,000 | $79.5 | $1,272,000 | 2024-10-25 |
| SINGLETON J MATTHEW | Derivatives Exercise | 16,000 | 2024-10-25 | ||
| Rouan Sarah Kathryn | Sale | -11,000 | $80.89 | $889,790 | 2024-10-25 |
| Rouan Sarah Kathryn | Derivatives Exercise | 11,000 | 2024-10-25 | ||
| Lian Brian | Sale | -216,130 | $70.43 | $15,221,777 | 2024-09-20 |
| Lian Brian | Derivatives Exercise | 166,130 | 2024-09-20 | ||
| SINGLETON J MATTHEW | Sale | -10,300 | $69.5 | $715,850 | 2024-09-20 |
| SINGLETON J MATTHEW | Derivatives Exercise | 10,300 | 2024-09-20 | ||
| SINGLETON J MATTHEW | Sale | -5,700 | $69.72 | $397,430 | 2024-08-22 |
| SINGLETON J MATTHEW | Derivatives Exercise | 5,700 | 2024-08-22 | ||
| Lian Brian | Sale | -1,000 | $69.9 | $69,900 | 2024-08-22 |
| Lian Brian | Derivatives Exercise | 1,000 | 2024-08-22 | ||
| SINGLETON J MATTHEW | Sale | -16,000 | $60.01 | $960,221 | 2024-08-19 |
| SINGLETON J MATTHEW | Derivatives Exercise | 16,000 | 2024-08-19 | ||
| Lian Brian | Sale | -112,870 | $65.33 | $7,373,425 | 2024-08-19 |
| Lian Brian | Derivatives Exercise | 112,870 | 2024-08-19 | ||
| SINGLETON J MATTHEW | Sale | -20,786 | $57.52 | $1,195,600 | 2024-08-14 |
| SINGLETON J MATTHEW | Derivatives Exercise | 20,786 | 2024-08-14 | ||
| Mancini Marianna | Sale | -18,026 | $56.98 | $1,027,121 | 2024-07-31 |
| Mancini Marianna | Grant, award...etc | 31,667 | 2024-07-31 | ||
| Lian Brian | Sale | -115,859 | $56.95 | $6,598,170 | 2024-07-31 |
| Lian Brian | Grant, award...etc | 204,333 | 2024-07-31 | ||
| ZANTE GREG | Sale | -16,136 | $56.96 | $919,107 | 2024-07-31 |
| ZANTE GREG | Grant, award...etc | 28,334 | 2024-07-31 | ||
| ZANTE GREG | Sale | -66,756 | $73.49 | $4,905,772 | 2024-05-03 |
| ZANTE GREG | Derivatives Exercise | 34,249 | 2024-05-03 | ||
| Mancini Marianna | Sale | -281,425 | $76.4 | $21,502,136 | 2024-05-02 |
| Mancini Marianna | Derivatives Exercise | 281,425 | 2024-05-02 | ||
| Mancini Marianna | Sale | -16,610 | $83.34 | $1,384,277 | 2024-03-27 |
| Mancini Marianna | Grant, award...etc | 31,667 | 2024-03-27 | ||
| ZANTE GREG | Sale | -16,610 | $83.34 | $1,384,277 | 2024-03-27 |
| ZANTE GREG | Grant, award...etc | 31,667 | 2024-03-27 | ||
| Lian Brian | Sale | -153,948 | $83.34 | $12,830,026 | 2024-03-27 |
| Lian Brian | Grant, award...etc | 221,667 | 2024-03-27 | ||
| Lian Brian | Sale | -162,815 | $85.22 | $13,875,094 | 2024-03-04 |
| Lian Brian | Grant, award...etc | 221,667 | 2024-03-04 | ||
| ZANTE GREG | Sale | -20,093 | $85.22 | $1,712,325 | 2024-03-04 |
| ZANTE GREG | Grant, award...etc | 31,667 | 2024-03-04 | ||
| Mancini Marianna | Sale | -16,958 | $85.22 | $1,445,161 | 2024-03-04 |
| Mancini Marianna | Grant, award...etc | 31,667 | 2024-03-04 | ||
| Lian Brian | Sale | -45,000 | $29.9 | $1,345,500 | 2024-02-09 |
| Lian Brian | Sale | -269,079 | $25.75 | $6,928,784 | 2024-02-08 |
| Lian Brian | Derivatives Exercise | 189,079 | 2024-02-08 | ||
| Rouan Sarah Kathryn | Sale | -25,000 | $28.05 | $701,250 | 2024-02-08 |
| Rouan Sarah Kathryn | Derivatives Exercise | 25,000 | 2024-02-08 | ||
| Lian Brian | Sale | -85,000 | $24.45 | $2,078,250 | 2024-01-31 |
| Lian Brian | Derivatives Exercise | 85,000 | 2024-01-31 | ||
| Lian Brian | Sale | -35,000 | $23.95 | $838,250 | 2024-01-30 |
| Lian Brian | Derivatives Exercise | 35,000 | 2024-01-30 | ||
| Rouan Sarah Kathryn | Sale | -30,000 | $23.05 | $691,500 | 2024-01-19 |
| Rouan Sarah Kathryn | Derivatives Exercise | 30,000 | 2024-01-19 | ||
| Lian Brian | Sale | -254,192 | $17.4 | $4,422,941 | 2024-01-04 |
| Lian Brian | Grant, award...etc | 310,000 | 2024-01-04 | ||
| ZANTE GREG | Sale | -77,994 | $17.4 | $1,357,096 | 2024-01-04 |
| ZANTE GREG | Grant, award...etc | 98,334 | 2024-01-04 | ||
| Mancini Marianna | Sale | -63,409 | $17.4 | $1,103,317 | 2024-01-04 |
| Mancini Marianna | Grant, award...etc | 98,334 | 2024-01-04 | ||
| Rowland Charles A Jr | Sale | -40,000 | $25 | $1,000,000 | 2023-05-18 |
| Rowland Charles A Jr | Derivatives Exercise | 40,000 | 2023-05-18 | ||
| MACARTNEY LAWSON | Sale | -16,000 | $24 | $384,000 | 2023-05-18 |
| MACARTNEY LAWSON | Derivatives Exercise | 16,000 | 2023-05-18 | ||
| Lian Brian | Sale | -45,000 | $22.45 | $1,010,250 | 2023-05-01 |
| MACARTNEY LAWSON | Sale | -16,000 | $22 | $352,061 | 2023-04-24 |
| MACARTNEY LAWSON | Derivatives Exercise | 16,000 | 2023-04-24 | ||
| Lian Brian | Sale | -35,000 | $21.45 | $750,750 | 2023-04-21 |
| ZANTE GREG | Sale | -7,500 | $20 | $150,000 | 2023-04-18 |
| ZANTE GREG | Derivatives Exercise | 7,500 | 2023-04-18 | ||
| MACARTNEY LAWSON | Sale | -20,786 | $20 | $415,720 | 2023-04-18 |
| MACARTNEY LAWSON | Derivatives Exercise | 20,786 | 2023-04-18 |
The information provided in this report about VKTX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Viking Therapeutics, Inc(NASDAQ:VKTX) 
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TR), ...
Website: http://www.vikingtherapeutics.com
Founded: 2012
Full Time Employees: 17
Sector: Healthcare
Industry: Biotechnology